Search academic texts

Information × Registration Number 0220U101036, 0118U003211 , R & D reports Title To develop actions to improve results of complex treatment of patients with advanced endometrial cancer and recurrences of this disease popup.stage_title Head Mikhanovskyi Oleksandr A., Доктор медичних наукSukhina Olena M., Доктор медичних наук Registration Date 31-01-2020 Organization State Organization "Grigoriev Institute for Medical Radiologiy of the National Academy of Medical Sciences of Ukraine" popup.description2 Object of stady: a complex method of treatment patients with advanced endometrial cancer and relapse of the disease. Objective: to increase the effectiveness of complex treatment of patients with advanced endometrial cancer and disease recurrence by individualizftion of treatment based on studying the molecular biological features of the tumor and determining their prognostic value. Methods of research and equipment: clinical, radiological, immunological, morphological, statistical. Ultrasound diagnostic system ClearVue 550, head. No. US01390112, 2013 p., Automatic hematology analyzer SF-3000 "SYSMEX". Theoretical and practical results: has been found that endometrial adenocarcinoma regression is most likely dependent on the degree of differentiation, the shape of tumor growth, the depth of its invasion into the myometrium, and the type of neoadjuvant therapy. The dystrophic cells of tumour cages progressively grow as far as the decline of degree of differentiation of adenocarcinoma. They are most pronounced in low-differentiated tumors after radiotherapy remote radiotherapy. The dependence of endometrial cancer pathomorphosis on neoadjuvant polychemotherapy, radiotherapy radiotherapy, which suppresses tumor proliferative properties and apoptosis activation, increases the volume of the damaged tumor. Novelty: For the first time, it has been proven that endometrial adenocarcinoma therapeutic pathomorphosis in patients with advanced endometrial cancer depends on the degree of differentiation, the shape of tumor growth, and the depth of its invasion into the myometrium. The level of expression of the investigated molecular - biological markers and estrogen and progesterone receptors depends on the presence of endometrial cancer recurrence. The effective of implementation: adjuvant chemotherapy treatment for patients with an increased risk of endometrial cancer can save about 15 thousand UAH. for one patient. Field of use: oncology. Product Description popup.authors Daniliuk Svitlana V. Zabobonina Larysa V. Krugova Iryna M. Mikhanovskyi Oleksandr A. Myrna Olha M. Moiseienko Yuliia A. Nasonova Alla M. Radchenko Oleksandr A. Sukhin Vladyslav S. Sukhina Olena M. Teplova Maryna A. Fedorenko Nataliya V. Kharchenko Yuliia V. Shchyt Nataliia M. popup.nrat_date 2020-04-02 Close